Press Releases

Watchdog: Bristol Myers, J&J’s Greed Put in Check As Judge Rejects Latest Challenge to Biden Rx Medicare Negotiation Action

Economic Security and Corporate Power
April 30, 2024

In a major win for seniors and patients struggling to afford their necessary medications, on Monday a U.S. District Judge rejected lawsuits from Bristol Myers Squibb and Johnson & Johnson seeking to block the Inflation Reduction Act’s measures giving Medicare the power to negotiate lower prices directly with drug manufacturers.

back to top